本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cullinan Therapeutics

10.87
+0.15001.40%
盤後10.910.0400+0.37%19:54 EST
成交量:55.23萬
成交額:597.15萬
市值:6.42億
市盈率:-2.95
高:11.23
開:10.70
低:10.45
收:10.72
52周最高:13.33
52周最低:5.68
股本:5,907.63萬
流通股本:3,605.51萬
量比:1.06
換手率:1.53%
股息:- -
股息率:- -
每股收益(TTM):-3.6809
每股收益(LYR):-3.1129
淨資產收益率:-40.18%
總資產收益率:-26.53%
市淨率:1.42
市盈率(LYR):-3.49

資料載入中...

公司資料

公司名字:
Cullinan Therapeutics
交易所:
NASDAQ
成立時間:
2016
員工人數:
111
公司地址:
One Main Street,Suite 1350,Cambridge,Massachusetts,United States
郵編:
02142
電話:
傳真:
- -
簡介:
Cullinan Therapeutics, Inc.於特拉華州註冊成立。該公司是一家生物製藥公司,專註於為癌症患者開發具有轉化潛力的腫瘤靶向治療和免疫腫瘤治療的多樣化渠道。

董事

名稱
職位
Anthony Rosenberg
Chairman of the Board
Nadim Ahmed
Director, President and Chief Executive Officer
David D. Meek
Independent Director
Mary T. Thistle
Independent Director
Stephen Webster
Independent Director
Andrew Allen
Director
Mittie Doyle
Director

股東

名稱
職位
Nadim Ahmed
Director, President and Chief Executive Officer
Mary Kay Fenton
Chief Financial Officer and Principal Accounting Officer
Corinne Savill
Chief Business Officer
Jacquelyn Sumer, Esq
Chief Legal Officer, Chief Compliance Officer and Secretary
Jeffrey Jones
Chief Medical Officer
Jennifer Michaelson
Chief Scientific Officer